Received grant in 2019

DCCC has funded 200,000 DKK to the project.

Establishing a national multidisciplinary DCCC circulating tumour DNA network (DCCC ctDNA) to improve the collaboration, research and clinical implementation of ctDNA based biomarkers in the management and treatment of cancer.

The aim of DCCC ctDNA is to stimulate and optimize Danish ctDNA research by facilitating national research studies lead by the DMCG’s. With the network we will create a unique forum, where researchers and clinicians with interest in ctDNA can meet, collaborate and formulate national protocols with the aim of improving cancer treatment in all of Denmark.

Multidisciplinary organisation
The DCCC ctDNA network protocol will be rooted in relevant DMCG's. The following DMCG's have shown interest in being the anchor for protocols involving ctDNA-based patient stratification: DCCC, DACG, DaBlaCa, DUCG and DaProCa.

Project stakeholders

Region Zealand

  • Niels Pallisgaard, Molecular Biologist, Department of Pathology, Zealand University Hospital, Roskilde Sygehus
  • Ismail Gogenur, Professor, Department of Surgery, Zealand University Hospital, Køge

Central Denmark Region

  • Lars Dyrskjøt, Professor, Department of Molecular Medicine (MOMA), Aarhus University Hospital
  • Karina Dalsgaard, Professor, Department of Molecular Medicine (MOMA), Aarhus University Hospital
  • Britt Elmedal Laursen, Consultant, Department of Molecular Medicine (MOMA), Aarhus University Hospital
  • Claus Lindbjerg Andersen, Professor, Department of Molecular Medicine (MOMA), Aarhus University Hospital
  • Boe Sandahl Sørensen, Professor, Department of Clinical Biochemistry, Aarhus University Hospital
  • Karen-Lise Garm Spindler, Chair of DACG, Professor, Consultant, Department of Oncology, Aarhus University Hospital
  • Lene Hjerrild Iversen, Chair of DCCG, Professor, Consultant, Department of Surgical Gastroenterology, Aarhus University Hospital
  • Jørgen Bjerggaard Jensen, Chair of DaBlaCa, Professor, Consultant, Department of Urology, Aarhus Universitetshospital
  • Michael Borre, Chair of DMCG.dk, DaProCa, DUCG, Professor, Consultant, Dept. of Urology, Aarhus University Hospital
  • Frank Viborg Mortensen, Professor, Department of Surgical Gastroenterology, Aarhus University Hospital
  • Anders Husted Madsen, Consultant, Department of Surgery, Regional Hospital West Jutland Herning
  • Kåre G Sunesen, Associate Professor, Speciality Registrar, Department of Surgery, Regional Hospital West Jutland Randers
  • Uffe Schou Løve, Consultant, Department of Surgery, Regional Hospital West Jutland Viborg
  • Søren Laurberg, Professor, Department of Clinical Medicine, Aarhus University

The North Denmark Region

  • Ole Thorlassius-Ussing, Professor, Department of Surgery, Aalborg University Hospital
  • Henrik Krarup, Consultant, Department of Clinical Biochemistry, Aalborg University Hospital
  • Andreas Carus, Consultant, Department of Oncology, Aalborg University Hospital

The Region of Southern Denmark

  • Per Vadgaard Andersen, Consultant, Department of Surgery, Odense University Hospital
  • Henrik Ditzel, Professor, Department of Cancer and Inflammation Research, Department of Molecular Medicine, University of Southern Denmark
  • Anders Jakobsen, Professor, Department of Oncology, Lillebælt Hospital, Vejle Sygehus
  • Henrik Jensen, Chair of DSKO, Consultant, Department of Oncology, Lillebælt Hospital, Vejle Sygehus
  • Rikke Fredslund Andersen, Molecular Biologist, Department of Clinical Biochemistry, Lillebælt Hospital, Vejle Sygehus

The Capital Region of Denmark

  • Morten Mau-Sørensen, Consultant, Phase 1 Unit, Department of Oncology, Rigshospitalet
  • Olga Østrup, Molecular Biologist, Unit of Genomic Medicine, Rigshospitalet
  • Barbara Malene Fischer, Consultant, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
  • Per Guldberg, Professor, Danish Cancer Society Research Center, Danish Cancer Society
  • Hans Jørgen Nielsen, Professor, Department of Surgery, Hvidovre Hospital
  • Helle Pappot, Consultant, Department of Oncology, Rigshospitalet
  • Gitte Lam, Consultant, Urology Research Unit, Herlev Hospital